Feed Preview

Acute Myeloid Leukemia

Acute Myeloid Leukemia diagram by undefined

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Top 20 most recent papers
The Lancet Oncology

Adjuvant denosumab in early breast cancer (D-CARE): an international, multicentre, randomised, controlled, phase 3 trial

The Lancet OncologyDecember 2, 2019
Robert Edward ColemanArlene Chan
Blood Cancer Journal

Features of non-activation dendritic state and immune deficiency in blastic plasmacytoid dendritic cell neoplasm (BPDCN)

Blood Cancer JournalDecember 6, 2019
Hannah C BeirdNaveen Pemmaraju
Science Immunology

T cell-derived interferon-γ programs stem cell death in immune-mediated intestinal damage

Science ImmunologyDecember 6, 2019
Shuichiro TakashimaAlan M Hanash

COMUNET: a tool to explore and visualize intercellular communication

bioRxivDecember 5, 2019
Maria Solovey, Antonio Scialdone
American Journal of Hematology

Increased mitochondrial apoptotic priming with targeted therapy predicts clinical response to re-induction chemotherapy

American Journal of HematologyDecember 5, 2019
Jacqueline S GarciaAnthony G Letai
Frontiers in Oncology

The Graft-Versus-Leukemia Effect in AML

Frontiers in OncologyNovember 19, 2019
Connor Sweeney, Paresh Vyas
British Journal of Haematology

Checkpoint inhibitors in AML: are we there yet?

British Journal of HaematologyDecember 6, 2019

Opportunities for immunotherapy in childhood acute myeloid leukemia

HematologyDecember 6, 2019
Adam J Lamble, Sarah K Tasian
Leukemia & Lymphoma

Prolonged administration of low-dose cytarabine and thioguanine in elderly patients with acute myeloid leukaemia (AML) achieves high complete remission rates and prolonged survival

Leukemia & LymphomaDecember 6, 2019
Christopher K ArthurWilliam S Stevenson

Mechanisms of and approaches to overcoming resistance to immunotherapy

HematologyDecember 6, 2019
Liora Michal Schultz, Rebecca A Gardner
Current Research in Translational Medicine

Evaluation of posaconazole antifungal prophylaxis in reducing the incidence of invasive aspergillosis in patients with acute myeloid leukemia

Current Research in Translational MedicineNovember 28, 2019
Lenaïg Le ClechPhilippe Saliou
British Journal of Haematology

Peripheral blood blast rate of clearance is an independent predictor of clinical response and outcomes in acute myeloid leukaemia

British Journal of HaematologyDecember 5, 2019
Noa G HoltzmanAshkan Emadi
British Journal of Haematology

Identification of a novel TFG-FGFR1 fusion gene in an acute myeloid leukaemia patient with t(3;8)(q12;p11)

British Journal of HaematologyDecember 4, 2019
Ting-Jing WangSu-ning Chen
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

ALS Cognitive Behavioral Screen (ALS-CBS): normative values for the Italian population and clinical usability

Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical NeurophysiologyDecember 5, 2019
Lucio TremolizzoALS-CBS Italian Study Group
Journal of Hematology & Oncology

LSD1/KDM1A inhibitors in clinical trials: advances and prospects

Journal of Hematology & OncologyDecember 4, 2019
Yuan FangBin Yu

Minimal residual disease and stem cell transplantation outcomes

HematologyDecember 6, 2019
Jacqueline CloosRichard Dillon

The growing landscape of FLT3 inhibition in AML

HematologyDecember 6, 2019
Catherine Rachel Smith

Retinoic Acid Receptors in Acute Myeloid Leukemia Therapy

CancersDecember 1, 2019
Orsola di Martino, John S Welch
Oncology Letters

An extra chromosome 9 derived from either a normal chromosome 9 or a derivative chromosome 9 in a patient with acute myeloid leukemia positive for t(9;11)(p21.3;q23.3): A case report

Oncology LettersDecember 1, 2019
Man GaoShi-bo Li
Frontiers in Pediatrics

Targeted Therapies for Pediatric AML: Gaps and Perspective

Frontiers in PediatricsNovember 15, 2019
Annalisa LonettiRiccardo Masetti

See more papers from this feed

Related Feeds

Acute Myeloid Leukaemia & RNA

Acute myeloid leukaemia (AML) is a common hematological type of cancer. As the population ages, there has been a rise in the frequency of AML. RNA expression has been used to see if there are different genetic profiles that exist within AML and whether these may underpin the variations in survival rates. Here is the latest research on AML and RNA.

Autoimmune Lymphoproliferative Syndrome

Autoimmune lymphoproliferative syndrome (ALPS) is a rare genetic disorder of abnormal lymphocyte survival caused by defective Fas mediated apoptosis. Discover the latest research on ALPS here.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Bone Marrow Neoplasms

Bone Marrow Neoplasms are cancers that occur in the bone marrow. Discover the latest research on Bone Marrow Neoplasms here.

CNS Lymphoma

In CNS lymphoma, cancerous cells from lymph tissues or other parts of the body form tumors in the brain and/or spinal cord. Here is the latest research on this rare non-Hodgkin lymphoma.

Castleman Disease

Castleman Disease is a rare lymphoproliferative disorder that can progress into lymphoma. Discover the latest research on Castleman Disease here.

Childhood Vascular Tumor: Genetics

Childhood vascular tumors are formed from cells related to blood vessels or lymph vessels. Here is the latest research on the genetics of childhood vascular tumors.

Chronic Myelogenous Leukemia

Chronic myelogenous leukemia (cml) is a clonal hematopoietic stem cell disorder characterized by the translocation and resultant production of the constitutively activated bcr-abl tyrosine kinase. Here is the latest research on this disease.

Composite Lymphoma

Composite Lymphoma involves different types of lymphoma cells concurrently. Here is the latest research on T-cell leukemia.

© 2019 Meta ULC. All rights reserved